Pharmasaga Co Ltd Sustainability Reports

Pharmasaga Co., Ltd. operates as a clinical-stage drug discovery and development company. It primarily focuses on producing first-in-class small molecule inhibitors, such as Pdia4 inhibitors, targeting type 1 and type 2 diabetes treatments.

Sector: Manufacturing

Country: Taiwan

Exchange: Taipei Exchange

FIGI: BBG01YLYQKT2

No reports are currently available in our catalogue.